All terms in HP

Label Id Description
Absent ankle pulse HP_0031271 [The pulsation of the posterior tibial artery behind the internal malleolus, or of the dorsalis pedis artery, cannot be detected on physical examination.]
cathartic CHEBI_75325 [Any substance that accelerates defecation. Compare with laxatives, which are substances that ease defecation (usually by softening faeces). A substance can be both a laxative and a cathartic.]
Abnormal thoracic duct morphology HP_0031278 [Any structural anomaly of the thoracic duct.]
Obstructive shock HP_0031276 [A type of shock characterized by inadequate cardiac preload due to obstructed venous return (e.g. pericardial tamponade, tension pneumothorax, abdominal compartment) or obstruction of arterial blood flow (e.g. pulmonary embolism).]
Hypovolemic shock HP_0031274 [A state of shock characterized by decreased circulating blood volume in relation to total vascular capacity. This type of shock is characterized by a reduction of diastolic filling pressures.]
Distributive shock HP_0031275 [A hyperdynamic process resulting from excessive vasodilatation. Impaired blood flow causes inadequate tissue perfusion, which can lead to end-organ damage]
Pulmonary arterial atherosclerosis HP_0031272 [Accumulation of lipids and inflammatory cells along the inner walls of the pulmonary artery.]
Elevated urinary 2,4-dihydroxybutyric acid level HP_6000992 [The amount of 2,4-dihydroxybutyric acid in the urine, normalized for urine concentration, is above the upper limit of normal.]
Elevated circulating 4-hydroxybutyric acid concentration HP_6000991 [Concentration of 4-hydroxybutyric acid in the blood circulation above the upper limit of normal.]
Lack of pupillary response to hydroxyamphetamine HP_6000994 [4-hydroxyamphetamine is used in eye drops to dilate the pupil, e.g.., to induce mydriasis for fundus examinations. This term refers to a lack of response of the pupil to topical application of 4-hydroxyamphetamine.]
Pupillary hypersensitivity to parasympathomimetic agents HP_6000993 [A higher than normal tendency of parasympathomimetic agents to induce miosis.]
Intraspinal extradural lipoma HP_6000996 [A lipoma (a benign encapsulated mass with lobulated mature adipose tissue enclosed by fibrous tissue) located within the spine but outside of the dura mater.]
Subcortical U fiber lesion HP_6000995 [Abnormal morphology of subcortical U fibers, typically as assessed by abnromal intensity on magnetic resonance imaging of the brain.]
Liver rupture HP_6000998 [Subcapsular hepatic rupture is characterized by the development of a hematoma, often quite large, beneath the liver capsule. An interval of days or hours may elapse between the time of injury and the first appearance of symptoms. A history of injury may be entirely lacking, or may be so unremarkable that it is elicited only by diligent interrogation. The hematoma tends to increase in size.]
Intranasal mass HP_6000997 [An abnormal enlargement or swelling localized to the nasal cavity. The word mass is usually used at an early stage of the diagnostic workup before the precise nature of the swelling has been determined.]
Elevated urinary mandelic acid HP_6000999 [The amount of mandelic acid in the urine, normalized for urine concentration, is above the upper limit of normal.]
Triangular tibia HP_0031260 [A short, dysplastic tibia with a triangular shape. Instead of the normal shaft configuration of the tibia, the tibia forms a triangle with the longest side corresponding to the proximal-distal dimension, and the apex of the triangle directed laterally.]
Abnormal CD69 upregulation upon TCR activation HP_0031267 [Any abnormality in the upregulation of CD69 on T cells after activation via the T cell receptor (TCR). Upregulation of CD69 is one of the earliest and most sensitive measures of antigen recognition in the periphery, and transient expression of CD69 is associated with positive selection in the thymus.]
Decreased CD69 upregulation upon TCR activation HP_0031268 [Reduced or impaired upregulation of CD69 on T cells after activation via the T cell receptor (TCR).]
Podocyte foot process effacement HP_0031266 [An anomaly of podocyte morphology characterized by the loss of the interdigitating foot process pattern (generally called foot process effacement; FPE). The term FPE designates the loss of the usual interdigitating pattern of foot processes of neighboring podocytes, leading to relatively broad expanses of podocyte processes covering the glomerular basement membrane (GBM). It is widely viewed as a pathological derangement that is associated with leakage of macromolecules such as albumin through the glomerular filtration barrier.]